Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
McKesson
Baxter
Merck
AstraZeneca

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Patent Applications for AZILECT

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

US Patent Applications for AZILECT

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial USE OF R-ENANTIOMER OF N-PROPARGYL-1-AMINOINDAN, SALTS, AND COMPOSITIONS THEREOF 2001-10-26 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2015-11-02
  Start Trial   Start Trial Individualization of therapy with Alzheimer's disease agents 2002-06-06 Abandoned -- Failure to Respond to an Office Action 2004-09-14
  Start Trial   Start Trial Pharmaceutical dosage forms including rasagiline 2005-07-26 Abandoned -- Failure to Respond to an Office Action 2012-04-03
  Start Trial   Start Trial Use of R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof 2005-06-17 Abandoned -- Failure to Respond to an Office Action 2008-02-27
  Start Trial   Start Trial Dosage forms with an enterically coated core tablet 2005-07-26 Abandoned -- Failure to Respond to an Office Action 2011-06-20
  Start Trial   Start Trial RASAGILINE FORMULATIONS OF IMPROVED CONTENT UNIFORMITY 2006-02-22 Patented Case 2010-09-29
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
AstraZeneca
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.